Exact Sciences Corp.

Release Summary

Exact Sciences Corp. (Nasdaq: EXAS) today announced that CMS has published an updated 2015 Clinical Laboratory Fee Schedule, which includes reimbursement for the company's Cologuard® test at $492.72.

Exact Sciences Corp.